Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Healthy Living Europe.
Press releases published on September 5, 2025
Global Rare Disease Leader AnnieGuard Ltd Named Stakeholder in Midlands Cancer Life Science Innovation & Partnership Hub
EIN Presswire
·
September 5, 2025
Global leader in AI-driven rare disease detection becomes stakeholder in NHS Cancer Alliances' collaborative innovation initiative LONDON, ENGLAND, UNITED KINGDOM, September 5, 2025 /EINPresswire.com/ -- AnnieGuard Ltd, the global leader in rare disease …
Dr. Nick Bontis Inspires Healthcare Leaders at Grand River Hospital Leadership Conference
EIN Presswire
·
September 5, 2025
Canada’s top keynote speaker Dr. Nick Bontis Inspires Healthcare Leaders to Embrace Digital Transformation and Knowledge Management KITCHENER, ONTARIO, CANADA, September 5, 2025 /EINPresswire.com/ -- Grand River Hospital welcomed internationally …
bonyf NV Cancels Planned Capital Increase Following Positive Strategic Developments
EIN Presswire
·
September 5, 2025
We announces that the capital increase previously under consideration has been cancelled, following a series of significant and positive business developments. KNOKKE-HEIST, KNOKKE-HEIST, BELGIUM, September 5, 2025 /EINPresswire.com/ -- bonyf NV (Ticker …
Luminari CRO Launches Revolutionary AI-Powered Platform to Transform Clinical Trial Efficiency and Drug Development
EIN Presswire
·
September 5, 2025
Announces $2M Pre-Seed Round and Strategic Collaboration with 20/15 Visioneers MIAMI , FL, UNITED STATES, September 5, 2025 /EINPresswire.com/ -- Luminari CRO, a pioneering clinical research organization, today announced its official launch with a …
The Companion Diagnostic Technologies Market To Grow At a CAGR of 18.3%
EIN Presswire
·
September 5, 2025
Companion diagnostic (CD) is an in-vitro diagnostic technique that provides information about therapeutic responses of patient to a specific treatment. WILMINGTON, DE, UNITED STATES, September 5, 2025 /EINPresswire.com/ -- The Companion Diagnostic …
Bioinformatics Market Is Projected To Reach $24,731.61 Million
EIN Presswire
·
September 5, 2025
The global bioinformatics market size generated $8,614.29 million in 2019, and is projected to reach $24,731.61 million by 2027, growing at a CAGR of 13.4%. WILMINGTON, DE, UNITED STATES, September 5, 2025 /EINPresswire.com/ -- The Bioinformatics Market …
InnoSyn B.V. and SynSilico B.V. Join Forces in Enzyme Engineering
EIN Presswire
·
September 5, 2025
SynSilico's computational enzyme engineering capabilities together with InnoSyn's biocatalysis expertise at scale is capturing the full potential of enzymes. GELEEN, LIMBURG, NETHERLANDS, September 5, 2025 /EINPresswire.com/ -- For more than two decades …
Revive Therapeutics Announces Extension of Proposed Private Placement
GlobeNewswire
·
September 5, 2025
TORONTO, Sept. 05, 2025 (GLOBE NEWSWIRE) -- Revive Therapeutics Ltd. (“Revive” or the “Company”) (OTCQB: RVVTF) (CSE: RVV) (FRANKFURT: 31R), a specialty life sciences company dedicated to developing innovative therapeutics for critical medical needs, …
AKT Health Announces Hakase AI to Transform Life Sciences with a Comprehensive AI Platform
EIN Presswire
·
September 5, 2025
Hakase AI unites Clinical, Commercial …
Helios Alliance Announces National Opioid Conference Featuring Former White House Drug Policy Director Dr. Rahul Gupta
GlobeNewswire
·
September 5, 2025
Mobile, Alabama , Sept. 05, 2025 (GLOBE NEWSWIRE) -- Helios Alliance, a nonprofit dedicated to improving public health outcomes, announced today that Dr. Rahul Gupta, former director of the White House Office of National Drug Control Policy, will headline …
DBV Technologies Establishes an At-The-Market (ATM) Program on Nasdaq
GlobeNewswire
·
September 5, 2025
Châtillon, France, September 5, 2025 DBV Technologies Establishes an At-The-Market (ATM) Program on Nasdaq DBV Technologies (Euronext: DBV – ISIN: FR0010417345 – Nasdaq Capital Market: DBVT) (the “Company”), a clinical-stage biopharmaceutical company, …
DBV Technologies met en place un Programme At-The-Market (ATM) sur le Nasdaq
GlobeNewswire
·
September 5, 2025
Châtillon, France, le 5 septembre (22:30 CEST) 2025 DBV Technologies met en place un Programme At-The-Market (ATM) sur le Nasdaq DBV Technologies (Euronext : DBV – ISIN : FR0010417345 – Nasdaq Capital Market : DBVT) (la « Société »), une société …
Publication relating to transparency notifications
GlobeNewswire
·
September 5, 2025
REGULATED INFORMATION Publication relating to transparency notifications Mont-Saint-Guibert (Belgium), September 5, 2025, 10:30 pm CET / 4:30 pm ET – In accordance with article 14 of the Act of 2 May 2007 on the disclosure of large …
Publication relative à des notifications de transparence
GlobeNewswire
·
September 5, 2025
INFORMATION RÉGLEMENTÉE Publication relative à des notifications de transparence Mont-Saint-Guibert (Belgique), le 5 septembre 2025, 22:30h CET / 16:30h ET – Conformément à l'article 14 de la loi du 2 mai 2007 relative à la publicité des …
ORIC Pharmaceuticals Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
GlobeNewswire
·
September 5, 2025
SOUTH SAN FRANCISCO, Calif. and SAN DIEGO, Sept. 05, 2025 (GLOBE NEWSWIRE) -- ORIC Pharmaceuticals, Inc. (Nasdaq:ORIC), a clinical stage oncology company focused on developing treatments that address mechanisms of therapeutic resistance, today announced …
Vera Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
GlobeNewswire
·
September 5, 2025
BRISBANE, Calif., Sept. 05, 2025 (GLOBE NEWSWIRE) -- Vera Therapeutics, Inc. (Nasdaq: VERA) today announced that, on September 4, 2025, the Compensation Committee of Vera’s Board of Directors granted inducement awards consisting of non-qualified stock …
89bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
GlobeNewswire
·
September 5, 2025
SAN FRANCISCO, Sept. 05, 2025 (GLOBE NEWSWIRE) -- 89bio, Inc. (the “Company” or “89bio”) (Nasdaq: ETNB), a clinical-stage biopharmaceutical company focused on the development and commercialization of innovative therapies for the treatment of liver and …
Rapport Therapeutics to Announce Topline Results for RAP-219 Phase 2a Trial in Focal Onset Seizures on Monday, September 8, 2025
GlobeNewswire
·
September 5, 2025
BOSTON and SAN DIEGO, Sept. 05, 2025 (GLOBE NEWSWIRE) -- Rapport Therapeutics, Inc. (Nasdaq: RAPP) (“Rapport” or the “Company”), a clinical-stage biotechnology company dedicated to the discovery and development of small molecule precision medicines for …
Artelo Biosciences Announces Closing of $3.0 Million Public Offering
GlobeNewswire
·
September 5, 2025
SOLANA BEACH, Calif., Sept. 05, 2025 (GLOBE NEWSWIRE) -- Artelo Biosciences, Inc. (Nasdaq: ARTL), a clinical-stage pharmaceutical company focused on modulating lipid-signaling pathways to develop treatments for people living with cancer, pain, dermatologic …
Gyre Therapeutics to Present at the H.C. Wainwright 27th Annual Global Investment Conference
GlobeNewswire
·
September 5, 2025
SAN DIEGO, Sept. 05, 2025 (GLOBE NEWSWIRE) -- Gyre Therapeutics (“Gyre”) (Nasdaq: GYRE), an innovative, commercial-stage biopharmaceutical company dedicated to advancing fibrosis-first therapies across organ systems affected by chronic disease, today …